GLPwatch
Comparison of Body Weight Change Through Different Smeglutide Administration Methods
NCT05616052 · Unknown status
Last updated 2026-05-28This clinical trial compares how different methods of administering semaglutide affect body weight change in adults.
Status Unknown status The sponsor has not confirmed the status recently.
Phase Phase 4 Monitors a drug already on the market.
Type Interventional (clinical trial)
Design Randomized, single-blind treatment study
Participants 80 people Planned (estimated).
Who can join Ages 18–75 · all sexes
Timeline Started 2022-12 · est. completion 2023-12
Where 1 site · China
What this study is testing ClinicalTrials.gov NCT05616052 ↗
Description as written by the study sponsor.
Investigators determined to detect the effect of smeglutide on body weight and metabolic indexes among overweight and obese participants through two different dosing programs.
Treatments tested
- Semaglutide also known as dosage regime Drug
treatment with different dosage regimes
| Main thing measured | weight change in kilograms |
|---|---|
| Sponsor | Huashan Hospital |
| Conditions studied | Weight Change, Body |
| GLP-1 drugs | — |
Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT05616052 ↗